Adenoid Cystic Carcinoma research hub
3 indexed studies · 2 currently recruiting
- recruitingPHASE1, PHASE2
Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma
This study is testing a new medicine, REM-422, for people with a type of cancer called Adenoid Cystic Carcinoma (ACC) that has come back, spread, or can't be removed by surgery. We want to see if it's safe and helps shrink the cancer.
United States · France - recruitingPHASE1
Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)
This study is testing a new drug, RGT-61159, for people with advanced adenoid cystic carcinoma (ACC) or colorectal cancer (CRC). It aims to see if the drug is safe and helps shrink tumors. It's for patients whose cancer has come back or spread and who have run out of other treatment options.
United States · Canada - ongoing, recruitingTherapeutic exploratory (Phase II)
The evaluation of the effectiveness, safety and tolerability of treatment, using a specialized prostate-specific membrane antigen (PSMA) labeled with Lutetium177, in patients with recurrent and/or metastatic adenoid cystic carcinoma originating from the salivary glands - an open, non-commercial clinical trial
This study is looking at a new treatment called Pluvicto for a rare type of cancer called adenoid cystic carcinoma, which starts in the salivary glands. Doctors want to see how safe and effective this special medicine is for patients whose cancer has come back or spread.
Poland